ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Formic Acid → 5-Chloro-N-[1-({3-[(formylamino)methyl]phenyl}methyl)-4-(methyloxy)-1H-indazol-3-yl]-2-thiophenesulfonamide

HRID 1874706
印刷

反応式

HRID 1874706 の反応式
[CH:1]([OH:3])=O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.C(N(CC)CC)C.Cl.[NH2:34][CH2:35][C:36]1[CH:37]=[C:38]([CH2:42][N:43]2[C:51]3[C:46](=[C:47]([O:52][CH3:53])[CH:48]=[CH:49][CH:50]=3)[C:45]([NH:54][S:55]([C:58]3[S:59][C:60]([Cl:63])=[CH:61][CH:62]=3)(=[O:57])=[O:56])=[N:44]2)[CH:39]=[CH:40][CH:41]=1>CN(C=O)C>[Cl:63][C:60]1[S:59][C:58]([S:55]([NH:54][C:45]2[C:46]3[C:51](=[CH:50][CH:49]=[CH:48][C:47]=3[O:52][CH3:53])[N:43]([CH2:42][C:38]3[CH:39]=[CH:40][CH:41]=[C:36]([CH2:35][NH:34][CH:1]=[O:3])[CH:37]=3)[N:44]=2)(=[O:56])=[O:57])=[CH:62][CH:61]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 284Formic AcidHCID 8471TriethylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate2 回HCID 66632476N-[1-{[3-(Aminomethyl)phenyl]methyl}-4-(methyloxy)-1H-indazol-3-yl]-5-chloro-2-thiophenesulfonamide hydrochloride

生成物 1

HCID 594560715-Chloro-N-[1-({3-[(formylamino)methyl]phenyl}methyl)-4-(methyloxy)-1H-indazol-3-yl]-2-thiophenesulfonamide
収率 36%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To a solution of formic acid (5 μL, 0.13 mmol) in dry DMF (0.3 mL) was added TBTU (34.7 mg, 0.108 mmol) followed with triethylamine (50.2 μl, 0.360 mmol). This mixture was stirred at room temperature for about 10 min before adding N-[1-{[3-(aminomethyl)phenyl]methyl}-4-(methyloxy)-1H-indazol-3-yl]-5-chloro-2-thiophenesulfonamide hydrochloride (for a preparation see Intermediate 4) (45 mg, 0.09 mmol). The resultant pale yellow mixture was stirred at room temperature overnight. LCMS showed very little reaction, so more acid (˜0.25 mL), followed with TBTU (˜30 mg) were added. This addition was repeated 3 more times over 20 h until by LCMS analysis, there was more product than SM. The reaction mixture was partitioned between ethylacetate (2 mL) and saturated sodium bicarbonate solution (2 mL). The aqueous was extracted with ethyl acetate (×2). The combined organic solutions were washed with water, brine, dried (Na2SO4) and concentrated in vacuo to leave a pale oil which crystalised on standing. This was dissolved in 1:1 MeOH:DMSO (1 mL) and purified by Mass Directed AutoPrep on supelcosil ABZ+Plus column eluting with a gradient of MeCN-Water (95:5+0.05% Formic acid)−Water (+0.1% Formic acid). The solvent was evaporated in vacuo to give the title compound (15.9 mg, 36%) as a pale yellow powder: LCMS (System A) RT=1.02 min, ES+ve m/z 491/493 (M+H)+.

後処理

  1. stirringThe resultant pale yellow mixture was stirred at room temperature overnight
  2. customreaction
  3. additionwere added
  4. additionThis addition
  5. customover 20 h
  6. customThe reaction mixture was partitioned between ethylacetate (2 mL) and saturated sodium bicarbonate solution (2 mL)
  7. extractionThe aqueous was extracted with ethyl acetate (×2)
  8. washThe combined organic solutions were washed with water, brine
  9. dry with materialdried (Na2SO4)
  10. concentrationconcentrated in vacuo
  11. customto leave a pale oil which
  12. customcrystalised
  13. dissolutionThis was dissolved in 1:1 MeOH
  14. customDMSO (1 mL) and purified by Mass Directed AutoPrep on supelcosil ABZ+Plus column
  15. washeluting with a gradient of MeCN-Water (95:5+0.05% Formic acid)−Water (+0.1% Formic acid)
  16. customThe solvent was evaporated in vacuo

出典と根拠

ORDレコード
ord-c4a82931dec54d02bda1c2b32cbf1917
出典データセット
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08304446B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート